{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:17:41Z","timestamp":1791339461714,"version":"4.3.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Mucopolysaccharidosis type I (MPS I) is a progressive multisystem lysosomal storage disease caused by deficiency of the enzyme \u03b1-L-iduronidase (IDUA). Patients present with a continuous spectrum of disease severity, and the most severely affected patients (Hurler phenotype; MPS I-H) develop progressive cognitive impairment. The treatment of choice for MPS I-H patients is haematopoietic stem cell transplantation, while patients with the more attenuated phenotypes benefit from enzyme replacement therapy.<\/jats:p>\n            <jats:p>The potential of newborn screening (NBS) for MPS I is currently studied in many countries. NBS for MPS I, however, necessitates early assessment of the phenotype, in order to decide on the appropriate treatment. In this study, we developed an algorithm to predict phenotypic severity in newborn MPS I patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Thirty patients were included in this study. Genotypes were collected from all patients and all patients were phenotypically categorized at an age of\u2009&gt;\u200918\u00a0months based on the clinical course of the disease. In 18 patients, IDUA activity in fibroblast cultures was measured using an optimized IDUA assay. Clinical characteristics from the first month of life were collected from 23 patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Homozygosity or compound heterozygosity for specific mutations which are associated with MPS I-H, discriminated a subset of patients with MPS I-H from patients with more attenuated phenotypes (specificity 100%, sensitivity 82%). Next, we found that enzymatic analysis of IDUA activity in fibroblasts allowed identification of patients affected by MPS I-H. Therefore, residual IDUA activity in fibroblasts was introduced as second step in the algorithm. Patients with an IDUA activity of &lt;\u20090.32\u00a0nmol x mg<jats:sup>-1<\/jats:sup> \u00d7 hr<jats:sup>-1<\/jats:sup> invariably were MPS I-H patients, while an IDUA activity of &gt;\u20090.66\u00a0nmol \u00d7 mg<jats:sup>-1<\/jats:sup> \u00d7 hr<jats:sup>-1<\/jats:sup> was only observed in more attenuated patients. Patients with an intermediate IDUA activity could be further classified by the presence of differentiating clinical characteristics, resulting in a model with 100% sensitivity and specificity for this cohort of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Using genetic, biochemical and clinical characteristics, all potentially available in the newborn period, an algorithm was developed to predict the MPS I phenotype, allowing timely initiation of the optimal treatment strategy after introduction of NBS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-1172-8-99","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T20:14:21Z","timestamp":1373400861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life"],"prefix":"10.1186","volume":"8","author":[{"given":"Sandra DK","family":"Kingma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline J","family":"Langereis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clasine M","family":"de Klerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Zoetekouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wagemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk","family":"IJlst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald JA","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits A","family":"Wijburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"van Vlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"596_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/adc.72.3.263","volume":"72","author":"JE Wraith","year":"1995","unstructured":"Wraith JE: The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child. 1995, 72: 263-267. 10.1136\/adc.72.3.263.","journal-title":"Arch Dis Child"},{"key":"596_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11011-012-9302-1","volume":"27","author":"D Campos","year":"2012","unstructured":"Campos D, Monaga M: Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms. Metab Brain Dis. 2012, 27: 121-129. 10.1007\/s11011-012-9302-1.","journal-title":"Metab Brain Dis"},{"key":"596_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","volume":"171","author":"K D'Aco","year":"2011","unstructured":"D'Aco K, Underhill L, Rangachari L, Arn P, Cox GF, Giugliani R, Okuyama T, Wijburg F, Kaplan P: Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry. Eur J Pediatr. 2011, 171: 911-919.","journal-title":"Eur J Pediatr"},{"key":"596_CR4","volume-title":"Harrison's Principles of Internal Medicine","author":"RJ Hopkin","year":"2005","unstructured":"Hopkin RJ, Grabowski GA, et al.: Lysosomal storage diseases. Harrison's Principles of Internal Medicine. 17th edition. Edited by: Fauci A, Kasper D, Braunwald E. New York: McGraw Hill; 2005.","edition":"17"},{"key":"596_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ajmg.1320200308","volume":"20","author":"M Roubicek","year":"1985","unstructured":"Roubicek M, Gehler J, Spranger J: The clinical spectrum of alpha-L-iduronidase deficiency. Am J Med Genet. 1985, 20: 471-481. 10.1002\/ajmg.1320200308.","journal-title":"Am J Med Genet"},{"key":"596_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/08035250510031584","volume":"94","author":"S Vijay","year":"2005","unstructured":"Vijay S, Wraith JE: Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr. 2005, 94: 872-877. 10.1080\/08035250510031584.","journal-title":"Acta Paediatr"},{"key":"596_CR7","first-page":"1","volume":"6","author":"MH De Ru","year":"2012","unstructured":"De Ru MH, Boelens JJ, Das AM, Jones SA, Van der Lee JH, Mahlaoui N, Mengel E, Offringa M, O'Meara A, Parini R, Rovelli A, Sykora KW, Vellodi A, Wynn RF, Wijburg FA: Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis. 2012, 6: 1-9.","journal-title":"Orphanet J Rare Dis"},{"key":"596_CR8","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","volume":"87","author":"C Peters","year":"1996","unstructured":"Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD, Henslee-Downey J, Trigg ME, Cowan MJ, Sanders J, Bunin N, Weinstein H, Lenarsky C, Falk P, Harris R, Bowen T, Williams TE, Grayson GH, Warkentin P, Sender L, Cool VA, Crittenden M, Packman S, Kaplan P, Lockman LA, Anderson J, Krivit W, Dusenbery K, Wagner J: Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood. 1996, 87: 4894-4902.","journal-title":"Blood"},{"key":"596_CR9","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","volume":"91","author":"C Peters","year":"1998","unstructured":"Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, Saunders EF, DeAlarcon PA, Twist C, Nachman JB, Hale GA, Harris RE, Rozans MK, Kurtzberg J, Grayson GH, Williams TE, Lenarsky C, Wagner JE, Krivit W: Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood. 1998, 91: 2601-2608.","journal-title":"Blood"},{"key":"596_CR10","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","volume":"31","author":"G Souillet","year":"2003","unstructured":"Souillet G, Guffon N, Maire I, Pujol M, Taylor P, Sevin F, Bleyzac N, Mulier C, Durin A, Kebaili K, Galambrun C, Bertrand Y, Froissart R, Dorche C, Gebuhrer L, Garin C, Berard J, Guibaud P: Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant. 2003, 31: 1105-1117. 10.1038\/sj.bmt.1704105.","journal-title":"Bone Marrow Transplant"},{"key":"596_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/adc.76.2.92","volume":"76","author":"A Vellodi","year":"1997","unstructured":"Vellodi A, Young EP, Cooper A, Wraith JE, Winchester B, Meaney C, Ramaswami U, Will A: Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child. 1997, 76: 92-99. 10.1136\/adc.76.2.92.","journal-title":"Arch Dis Child"},{"key":"596_CR12","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","volume":"121","author":"JJ Boelens","year":"2013","unstructured":"Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, Wraith E, Cavazzana-Calvo M, Rovelli A, Fischer A, Tolar J, Prasad VK, Escolar M, Gluckman E, O'Meara A, Orchard PJ, Veys P, Eapen M, Kurtzberg J, Rocha V: Outcomes of transplantation using various hematopoietic cell sources in children with Hurler's syndrome after myeloablative conditioning. Blood. 2013, 121: 3981-3987. 10.1182\/blood-2012-09-455238.","journal-title":"Blood"},{"key":"596_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1542\/peds.2007-3847","volume":"123","author":"LA Clarke","year":"2009","unstructured":"Clarke LA, Wraith JE, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Sidman M, Kakkis ED, Cox GF: Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics. 2009, 123: 229-240. 10.1542\/peds.2007-3847.","journal-title":"Pediatrics"},{"key":"596_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1056\/NEJM200101183440304","volume":"344","author":"ED Kakkis","year":"2001","unstructured":"Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, Izykowski B, Phillips J, Doroshow R, Walot I, Hoft R, Neufeld EF: Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med. 2001, 344: 182-188. 10.1056\/NEJM200101183440304.","journal-title":"N Engl J Med"},{"key":"596_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1542\/peds.2008-0416","volume":"123","author":"J Muenzer","year":"2009","unstructured":"Muenzer J, Wraith JE, Clarke LA: Mucopolysaccharidosis I: Management and Treatment Guidelines. Pediatrics. 2009, 123: 19-29. 10.1542\/peds.2008-0416.","journal-title":"Pediatrics"},{"key":"596_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","volume":"90","author":"M Sifuentes","year":"2007","unstructured":"Sifuentes M, Doroshow R, Hoft R, Mason G, Walot I, Diament M, Okazaki S, Huff K, Cox GF, Swiedler SJ, Kakkis ED: A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab. 2007, 90: 171-180. 10.1016\/j.ymgme.2006.08.007.","journal-title":"Mol Genet Metab"},{"key":"596_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","volume":"144","author":"JE Wraith","year":"2004","unstructured":"Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF: Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr. 2004, 144: 581-588. 10.1016\/j.jpeds.2004.01.046.","journal-title":"J Pediatr"},{"key":"596_CR18","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1542\/peds.2006-2156","volume":"120","author":"JE Wraith","year":"2007","unstructured":"Wraith JE, Beck M, Lane R, van der Van der Ploeg A, Shapiro E, Xue Y, Kakkis ED, Guffon N: Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase). Pediatrics. 2007, 120: e37-e46. 10.1542\/peds.2006-2156.","journal-title":"Pediatrics"},{"key":"596_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1542\/peds.2009-1728","volume":"125","author":"O Gabrielli","year":"2010","unstructured":"Gabrielli O, Clarke LA, Bruni S, Coppa GV: Enzyme-Replacement Therapy in a 5-Month-Old Boy With Attenuated Presymptomatic MPS I: 5-Year Follow-up. Pediatrics. 2010, 125: 183-187. 10.1542\/peds.2009-1728.","journal-title":"Pediatrics"},{"key":"596_CR20","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1373\/clinchem.2008.115410","volume":"54","author":"S Blanchard","year":"2008","unstructured":"Blanchard S, Sadilek M, Scott CR, Turecek F, Gelb MH: Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I. Clin Chem. 2008, 54: 2067-2070. 10.1373\/clinchem.2008.115410.","journal-title":"Clin Chem"},{"key":"596_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ymgme.2012.09.024","volume":"107","author":"J De Ruijter","year":"2012","unstructured":"De Ruijter J, De Ru MH, Wagemans T, Ijlst L, Lund AM, Orchard PJ, Schaefer PB, Wijburg FA, Van Vlies N: Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III. Mol Genet Metab. 2012, 107: 705-710. 10.1016\/j.ymgme.2012.09.024.","journal-title":"Mol Genet Metab"},{"key":"596_CR22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/clinchem\/47.4.780","volume":"47","author":"NA Chamoles","year":"2001","unstructured":"Chamoles NA, Blanco M, Gaggioli D: Diagnosis of \u00e1-L-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis. Clin Chem. 2001, 47: 780-781.","journal-title":"Clin Chem"},{"key":"596_CR23","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","volume":"50","author":"Y Li","year":"2004","unstructured":"Li Y, Scott CR, Chamoles NA, Ghavami A, Pinto BM, Turecek F, Gelb MH: Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem. 2004, 50: 1785-1796. 10.1373\/clinchem.2004.035907.","journal-title":"Clin Chem"},{"key":"596_CR24","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.ymgme.2011.11.038","volume":"105","author":"B Burton","year":"2012","unstructured":"Burton B, Charrow J, Angle B, Widera S, Waggoner D: A pilot newborn screening program for lysosomal storage disorders (LSD) in Illinois. Mol Genet Metab. 2012, 105: S23-S24.","journal-title":"Mol Genet Metab"},{"key":"596_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ymgme.2012.08.008","volume":"107","author":"MH De Ru","year":"2012","unstructured":"De Ru MH, Bouwman MG, Wijburg FA, Van Zwieten MCB: Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening. Mol Genet Metab. 2012, 107: 501-507. 10.1016\/j.ymgme.2012.08.008.","journal-title":"Mol Genet Metab"},{"key":"596_CR26","volume-title":"J Pediatr","author":"CR Scott","year":"2013","unstructured":"Scott CR, Elliott S, Buroker N, Thomas LI, Keutzer J, Glass M, Gelb MH, Turecek F: Identification of Infants at Risk for Developing Fabry, Pompe, or Mucopolysaccharidosis-I from Newborn Blood Spots by Tandem Mass Spectrometry. J Pediatr. 2013, 10.1016\/j.jpeds.2013.01.031."},{"key":"596_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s004390100606","volume":"109","author":"CE Beesley","year":"2001","unstructured":"Beesley CE, Meaney CA, Greenland G, Adams V, Vellodi A, Young EP, Winchester BG: Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations. Hum Genet. 2001, 109: 503-511. 10.1007\/s004390100606.","journal-title":"Hum Genet"},{"key":"596_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00125817-200211000-00004","volume":"4","author":"P Li","year":"2002","unstructured":"Li P, Wood T, Thompson JN: Diversity of mutations and distribution of single nucleotide polymorphic alleles in the human alpha-L-iduronidase (IDUA) gene. Genet Med. 2002, 4: 420-426. 10.1097\/00125817-200211000-00004.","journal-title":"Genet Med"},{"key":"596_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-7-22","volume":"7","author":"MH De Ru","year":"2012","unstructured":"De Ru MH, Teunissen QGA, Van der Lee JH, Beck M, Bodamer OA, Clarke LA, Hollak CE, Lin SP, Munoz Rojas MV, Pastores GM, Raiman JA, Scarpa M, Treacy EP, Tylki-Szymanska A, Wraith JE, Zeman J, Wijburg FA: Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure. Orphanet J Rare Dis. 2012, 7: 1-9. 10.1186\/1750-1172-7-1.","journal-title":"Orphanet J Rare Dis"},{"key":"596_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0925-4439(98)00046-5","volume":"1407","author":"S Bunge","year":"1998","unstructured":"Bunge S, Clemets PR, Byers S, Kleijer WJ, Brooks DA, Hopwood JJ: Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Biochim Biophys Acta. 1998, 1407: 249-256. 10.1016\/S0925-4439(98)00046-5.","journal-title":"Biochim Biophys Acta"},{"key":"596_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/humu.20081","volume":"24","author":"G Yogalingam","year":"2004","unstructured":"Yogalingam G, Guo XH, Muller VJ, Brooks DA, Clements PR, Kakkis ED, Hopwood JJ: Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy. Hum Mutat. 2004, 24: 199-207. 10.1002\/humu.20081.","journal-title":"Hum Mutat"},{"key":"596_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2004.09.004","volume":"84","author":"M Fuller","year":"2005","unstructured":"Fuller M, Brooks DA, Evangelista M, Hein LK, Hopwood JJ, Meikle PJ: Prediction of neuropathology in mucopolysaccharidosis I patients. Mol Genet Metab. 2005, 84: 18-24. 10.1016\/j.ymgme.2004.09.004.","journal-title":"Mol Genet Metab"},{"key":"596_CR33","doi-asserted-by":"publisher","first-page":"e2189","DOI":"10.1002\/humu.21479","volume":"32","author":"F Bertola","year":"2011","unstructured":"Bertola F, Filocamo M, Casati G, Mort M, Rosano C, Tylki-Szymanska A, Tuysuz B, Gabrielli O, Grossi S, Scarpa M, Parenti G, Antuzzi D, Dalmau J, Rocco MD, Vici CD, Okur I, Rosell J, Rovelli A, Furlan F, Rigoldi M, Biondi A, Cooper DN, Parini R: IDUA mutational profiling of a cohort of 102 European patients with Mucopolysaccharidosis type I: identification and characterization of 35 novel \u00e1-L-iduronidase (IDUA) alleles. Hum Mutat. 2011, 32: e2189-e2210. 10.1002\/humu.21479.","journal-title":"Hum Mutat"},{"key":"596_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/hmg\/3.6.861","volume":"3","author":"S Bunge","year":"1994","unstructured":"Bunge S, Kleijer WJ, Steglich C, Beck M, Zuther C, Morris CP, Schwinger E, Hopwood JJ, Scott HS, Gal A: Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common alpha-L-iduronidase mutations (W402X and Q70X) among European patients. Hum Mol Genet. 1994, 3: 861-866. 10.1093\/hmg\/3.6.861.","journal-title":"Hum Mol Genet"},{"key":"596_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1746-1596-6-47","volume":"6","author":"L Chkioua","year":"2011","unstructured":"Chkioua L, Khedhiri S, Turkia HB, Tcheng R, Froissart R, Chahed H, Ferchichi S, Ben Dridi MF, Vianey-Saban C, Laradi S, Miled A: Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients. Diagn Pathol. 2011, 6: 47-10.1186\/1746-1596-6-47.","journal-title":"Diagn Pathol"},{"key":"596_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1096-7192(02)00200-7","volume":"78","author":"U Matte","year":"2003","unstructured":"Matte U, Yogalingam G, Brooks D, Leistner S, Schwartz I, Lima L, Norato DY, Brum JM, Beesley C, Winchester B, Giugliani R, Hopwood JJ: Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients. Mol Genet Metab. 2003, 78: 37-43. 10.1016\/S1096-7192(02)00200-7.","journal-title":"Mol Genet Metab"},{"key":"596_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.GIM.0000078027.83236.49","volume":"5","author":"NJ Terlato","year":"2003","unstructured":"Terlato NJ, Cox GF: Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype?. Genet Med. 2003, 5: 286-294. 10.1097\/01.GIM.0000078027.83236.49.","journal-title":"Genet Med"},{"key":"596_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/humu.9051","volume":"20","author":"N Venturi","year":"2002","unstructured":"Venturi N, Rovelli A, Parini R, Menni F, Brambillasca F, Bertagnolio F, Uziel G, Gatti R, Filocamo M, Donati MA, Biondi A, Goldwurm S: Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations. Hum Mutat. 2002, 20: 231.","journal-title":"Hum Mutat"},{"key":"596_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1006\/mgme.1998.2745","volume":"65","author":"EY Voskoboeva","year":"1998","unstructured":"Voskoboeva EY, Krasnopolskaya XD, Mirenburg TV, Weber B, Hopwood JJ: Molecular genetics of mucopolysaccharidosis type I: mutation analysis among the patients of the former Soviet Union. Mol Genet Metab. 1998, 65: 174-180. 10.1006\/mgme.1998.2745.","journal-title":"Mol Genet Metab"},{"key":"596_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1399-0004.2011.01680.x","volume":"81","author":"X Wang","year":"2012","unstructured":"Wang X, Zhang W, Shi H, Qiu Z, Meng Y, Yao F, Wei M: Mucopolysaccharidosis I mutations in Chinese patients: identification of 27 novel mutations and 6 cases involving prenatal diagnosis. Clin Genet. 2012, 81: 443-452. 10.1111\/j.1399-0004.2011.01680.x.","journal-title":"Clin Genet"},{"key":"596_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1590\/S1415-47572011005000006","volume":"34","author":"L Sun","year":"2011","unstructured":"Sun L, Li C, Song X, Zheng N, Zhang H, Dong G: Three novel alpha-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families. Genet Mol Biol. 2011, 34: 195-200. 10.1590\/S1415-47572011005000006.","journal-title":"Genet Mol Biol"},{"key":"596_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0009-8981(79)90121-9","volume":"92","author":"JJ Hopwood","year":"1979","unstructured":"Hopwood JJ, Muller V, Smithson A, Baggett N: A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes. Clin Chim Acta. 1979, 92: 257-265. 10.1016\/0009-8981(79)90121-9.","journal-title":"Clin Chim Acta"},{"key":"596_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0140-6736(78)90441-5","volume":"1","author":"JL Stirling","year":"1978","unstructured":"Stirling JL, Robinson D, Fensom AH, Benson PF, Baker JE: Fluorimetric assay for prenatal detection of Hurler and Scheie homozygotes or heterozygotes. Lancet. 1978, 1: 147.","journal-title":"Lancet"},{"key":"596_CR44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193: 265-275.","journal-title":"J Biol Chem"},{"key":"596_CR45","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10545-012-9538-2","volume":"36","author":"MH De Ru","year":"2013","unstructured":"De Ru MH, Van der Tol L, Van VN, Bigger BW, Hollak CE, Ijlst L, Kulik W, Van LH, Saif MA, Wagemans T, Van der Wal WM, Wanders RJ, Wijburg FA: Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans. J Inherit Metab Dis. 2013, 36: 247-255. 10.1007\/s10545-012-9538-2.","journal-title":"J Inherit Metab Dis"},{"key":"596_CR46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1651-2227.1995.tb13640.x","volume":"84","author":"MA Cleary","year":"1995","unstructured":"Cleary MA, Wraith JE: The presenting features of mucopolysaccharidosis type IH (Hurler syndrome). Acta Paediatr. 1995, 84: 337-339. 10.1111\/j.1651-2227.1995.tb13640.x.","journal-title":"Acta Paediatr"},{"key":"596_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2214.1996.tb00420.x","volume":"22","author":"GA Colville","year":"1996","unstructured":"Colville GA, Bax MA: Early presentation in the mucopolysaccharide disorders. Child Care Health Dev. 1996, 22: 31-36. 10.1111\/j.1365-2214.1996.tb00420.x.","journal-title":"Child Care Health Dev"},{"key":"596_CR48","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S0022-3476(89)80565-7","volume":"114","author":"MD Donaldson","year":"1989","unstructured":"Donaldson MD, Pennock CA, Berry PJ, Duncan AW, Cawdery JE, Leonard JV: Hurler syndrome with cardiomyopathy in infancy. J Pediatr. 1989, 114: 430-432. 10.1016\/S0022-3476(89)80565-7.","journal-title":"J Pediatr"},{"key":"596_CR49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF01799658","volume":"9","author":"RW Watts","year":"1986","unstructured":"Watts RW, Spellacy E, Adams JH: Neuropathological and clinical correlations in Hurler disease. J Inherit Metab Dis. 1986, 9: 261-272. 10.1007\/BF01799658.","journal-title":"J Inherit Metab Dis"},{"key":"596_CR50","first-page":"973","volume":"53","author":"HS Scott","year":"1993","unstructured":"Scott HS, Litjens T, Nelson PV, Thompson PR, Brooks DA, Hopwood JJ, Morris CP: Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes. Am J Hum Genet. 1993, 53: 973-986.","journal-title":"Am J Hum Genet"},{"key":"596_CR51","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","volume":"2","author":"JR Hobbs","year":"1981","unstructured":"Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Cahmber D, Henry K, James DC, Lucas CF, Rogers TR, Benson PF, Tansley LR, Patrick AD, Mossman J, Young EP: Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet. 1981, 2: 709-712.","journal-title":"Lancet"},{"key":"596_CR52","unstructured":"HGMD\u00ae.http:\/\/www.hgmd.cf.ac.uk\/,"},{"key":"596_CR53","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.ymgme.2012.11.111","volume":"108","author":"T Herzog","year":"2013","unstructured":"Herzog T, Ou L, Whitley C: Increased substrate concentration boosts enzyme activity levels of fluorometric a-L-iduronidase enzyme activity assay. Mol Genet Metab. 2013, 108: S48.","journal-title":"Mol Genet Metab"},{"key":"596_CR54","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1136\/ard.2008.095315","volume":"68","author":"M Aldenhoven","year":"2009","unstructured":"Aldenhoven M, Sakkers RJ, Boelens J, De Koning TJ, Wulffraat NM: Musculoskeletal manifestations of lysosomal storage disorders. Ann Rheum Dis. 2009, 68: 1659-1665. 10.1136\/ard.2008.095315.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 5","key":"596_CR55","doi-asserted-by":"publisher","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","volume":"50","author":"KK White","year":"2011","unstructured":"White KK: Orthopaedic aspects of mucopolysaccharidoses. Rheumatology (Oxford). 2011, 50 (Suppl 5): v26-v33. 10.1093\/rheumatology\/ker393.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-8-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:34:29Z","timestamp":1630542869000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-8-99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-8-99","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]},"assertion":[{"value":"3 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"99"}}